“The Timberwolves Team is the first professional sports organization to use the CVProfilor^® System in their routine health assessment. We are pleased to see their interest in providing a baseline health status of the team’s cardiovascular system,” said Greg H. Guettler, HDI President.

Jay N. Cohn, M.D., Professor of Medicine in the Cardiovascular Division at the University of Minnesota and Medical Advisor to HDI, reviewed the team’s CVProfiles™ with Timberwolves' team physician, Sheldon R. Burns, M.D. “Maintaining the team’s health is one of the ways for us to ensure a winning team. The CVProfilor^® provides us with additional information that we can use to make certain that our team is one of the healthiest in the NBA,” said Dr. Burns.

“Cardiovascular disease is the single largest cause of death in the United States,” commented Dr. Cohn. “High blood pressure is very common in our society and an arterial health assessment provides a good indication as to whether or not an individual is at early risk. Many people have inherited risk and do not realize it until it’s too late. The CVProfilor^® provides an early indication of risk even before overt signs such as high blood pressure appear. The CVProfilor^® is a test that everyone – even athletes – can benefit from,” added Dr. Cohn.

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research.  These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results.  Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2000 Annual Report on Form 10-KSB, as amended, under the caption “Risk Factors,” as well as others not now anticipated.

CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
  
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Investor Relations: Jens Dalsgaard and Tony Altavilla,
Managing Directors
Redwood Consultants, LLC
Mill Valley, CA 94941
415-380-0500

Contact: Greg H. Guettler, President